Catalyst
Slingshot members are tracking this event:
Vitae expects to report top-line data from Phase 2 clinical trial of VTP-43742 in psoriasis patients in the second half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VTAE | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 16, 2016
Occurred Source:
http://ir.vitaepharma.com/phoenix.zhtml?c=219654&p=irol-newsArticle&ID=2149044
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Psoriasis, Vtp-43742
